CN1308021C - Antivirus oral liquid - Google Patents

Antivirus oral liquid Download PDF

Info

Publication number
CN1308021C
CN1308021C CNB021364745A CN02136474A CN1308021C CN 1308021 C CN1308021 C CN 1308021C CN B021364745 A CNB021364745 A CN B021364745A CN 02136474 A CN02136474 A CN 02136474A CN 1308021 C CN1308021 C CN 1308021C
Authority
CN
China
Prior art keywords
oral liquid
chinese medicines
traditional chinese
antivirus
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021364745A
Other languages
Chinese (zh)
Other versions
CN1475244A (en
Inventor
吴圣楣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB021364745A priority Critical patent/CN1308021C/en
Publication of CN1475244A publication Critical patent/CN1475244A/en
Application granted granted Critical
Publication of CN1308021C publication Critical patent/CN1308021C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to oral liquid of pure traditional Chinese medicines, namely, antivirus oral liquid for treating fever caused by virus infection, which is prepared by adding other traditional Chinese medicines, such as isatis roots, etc., on the basis of four traditional Chinese medicines, such as paris polyphylla, baical skullcap root, gypsum and gypsum rubrum. Clinical practices of scores of years prove that the oral liquid has the effects of clearing heat and removing toxicity and virus resistance, and has an effective rate 95.6% when the oral liquid is used for treating a virus cold, pharyngitis, acute bronchitis, tonsillitis and parotitis, and a relapse is not apt to occur after the fever is reduced. The oral liquid is obviously superior to other antipyretic analgesics. The antivirus oral liquid has the advantages of no side effect, simple preparation process and low cost. Thereby, the antivirus oral liquid is the ideal oral liquid of pure traditional Chinese medicines, which is used for treating the fever caused by the virus infection, etc.

Description

Antivirus oral liquid
The present invention relates to a kind of pure Chinese medicine oral liquid---antivirus oral liquid that viral infection etc. causes heating for the treatment of.
The heating that viral infection causes is common clinically disease, but the treatment of the heating that viral infection is caused mainly is a symptomatic treatment owing to lack antiviral specific medicament, as having a rest, great quantity of water drinking, reduces temperature and mitigation symptoms.Antipyretic commonly used such as acetaminophen, hundred clothes are given repeated exhortations, paracetamol etc. owing to do not have antivirus action, after bringing down a fever easily repeatedly.Have the medicine of antivirus action such as interferon etc. and but do not have the antipyretic effect, can cause heating on the contrary, can not alleviate patient's symptom, and need drug administration by injection, use inconveniently, the price of medicine is also expensive, causes certain financial burden to patient.Other antiviral drugs commonly used mainly are nucleoside analogs, by disturbing the synthetic of DNA, suppress viral dna polymerase and bring into play antiviral effect, as vidarabine (Ara-a) and Ara-AMP, but its late result is not better than the placebo group, and bigger toxicity, side effect is arranged.The ucleosides antiviral drugs lamivudine of a new generation also has side reactions such as headache, discomfort, tired, stomachache and diarrhoea, and costs an arm and a leg.Whether is there there a kind of cheap and good-quality medicine, existing antiviral effect, the effect that having again brings down a fever alleviates patient symptom?
The purpose of this invention is to provide that a kind of therapeutic effect is remarkable, side effect is little, cost is lower, have heat-clearing and toxic substances removing, the pure Chinese medicinal preparation of antiviral effect.Be mainly used in viral infection such as viral influenza, pharyngitis, acute bronchitis, tonsillitis, parotitis and cause the treatment of heating.
Purpose of the present invention can reach by the following method: made by Rhizoma Paridis, Radix Scutellariae, Gypsum Fibrosum, Mirabilitum crystallina four flavor Chinese medicines, the ratio between the four flavor Chinese medicines (parts by weight) is a Rhizoma Paridis: Radix Scutellariae: Gypsum Fibrosum: Mirabilitum crystallina=3~20: 5~15: 5~70: 3~40.Can add on the basis of this four Chinese medicine that also other Chinese medicines such as Radix Isatidis, Radix Glycyrrhizae etc. increase the curative effect of medicine.Its processing technology is that Gypsum Fibrosum and Mirabilitum crystallina added decocting earlier 20~60 minutes with medical herbs immersion (submergence) 1~2 hour, and then with medical herbs and Gypsum Fibrosum is put in immersion and the Mirabilitum crystallina decocting liquid was fried in shallow oil 20~60 minutes together again, filtered juice is a medicinal liquid.
The present invention is on the basis of clinical practice for many years, goes through years of researches, adjusts prescription and dosage and makes.Infect the medicine cause and compared tangible advantage with the existing poison that is used for the treatment of, after the Drug therapy with this prescription, patient's heat is stepped back and is difficult for repeatedly, and the effect of bringing down a fever is remarkable.Rhizoma Paridis in the present invention prescription has antimicrobial, relievings asthma, antitussive action; Radix Scutellariae has antimicrobial, antiinflammatory antiallergic action, antipyretic effect; The main component of Gypsum Fibrosum is a hydrous calcium sulfate, and report has antipyretic effect; Mirabilitum crystallina has resolving heat and reducing pathogenic fire, sharp key, repercussive effect.Four Chinese medicine is combined, and has complementary and collaborative effect through special its curative effect of the oral liquid of being processed into, and has heat-clearing and toxic substances removing, antiviral effect.Be used for the treatment that viral infection such as viral influenza, pharyngitis, acute bronchitis, tonsillitis, parotitis cause heating effectively.Clinical studies show is divided into two groups at random with the fever patient (38 ℃~40 ℃ of body temperature) of 2658 routine viral infection, and wherein among the 1658 routine patients with the antivirus oral liquid treatment, the 2nd day body temperature of 1585 examples returns to normally, and not repeatedly; And in the fever patient that the 1000 routine viral infection for the treatment of with acetaminophen cause, have only 460 examples the 2nd
It body temperature returns to normally, not repeatedly.Evident difference (P<0.01) is relatively arranged between two groups.Show that the heating that antivirus oral liquid causes viral infection has tangible curative effect, do blood, urine, stool routine and hepatic and renal function inspection before and after the treatment, no abnormality seen changes, and have no side effect, and processing technology is simple, and cost is lower.
The present invention is further described in conjunction with the embodiments: antivirus oral liquid adds that by Rhizoma Paridis, Radix Scutellariae, Gypsum Fibrosum, Mirabilitum crystallina four flavor Chinese medicines Radix Isatidis makes, and the ratio of Chinese medicine of the five flavours (parts by weight) is a Rhizoma Paridis: Radix Scutellariae: Radix Isatidis: give birth to cream: Mirabilitum crystallina=15: 10: 15: 60: 30.With three flavor medical herbs immersions (submergence) 1 hour, Gypsum Fibrosum and Mirabilitum crystallina were decocted first 20 minutes, then the immersion of medical herbs and medical herbs were put into Gypsum Fibrosum and Mirabilitum crystallina and fried in shallow oil together 20 minutes again, and filtrate both had been medicine.Usage and dosage: 3 times on the oral one, shared two days, each consumption: 6 months~3 years old 15 milliliters; 3~10 years old 50 milliliters; More than 10 years old 100 milliliters.

Claims (3)

1. Chinese medicine oral liquid for the treatment of viral infection, the raw material of wherein making active ingredient mainly forms and the weight portion proportioning is: Rhizoma Paridis: Radix Scutellariae: Gypsum Fibrosum: Mirabilitum crystallina=3 ~ 20: 5 ~ 15: 5 ~ 70: 3 ~ 40.
2. the Chinese medicine oral liquid of treatment viral infection according to claim 1 wherein also can add Radix Isatidis, Radix Glycyrrhizae.
3. the Chinese medicine oral liquid of treatment viral infection according to claim 1 and 2, it is characterized in that: water was with medical herbs submergence 1 ~ 2 hour, Gypsum Fibrosum and Mirabilitum crystallina were decocted first 20 ~ 60 minutes, then medical herbs and immersion were put into the decocting liquid of Gypsum Fibrosum and Mirabilitum crystallina and fried in shallow oil together 20 ~ 60 minutes again.Filtered juice is medicinal liquid.
CNB021364745A 2002-08-13 2002-08-13 Antivirus oral liquid Expired - Fee Related CN1308021C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021364745A CN1308021C (en) 2002-08-13 2002-08-13 Antivirus oral liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021364745A CN1308021C (en) 2002-08-13 2002-08-13 Antivirus oral liquid

Publications (2)

Publication Number Publication Date
CN1475244A CN1475244A (en) 2004-02-18
CN1308021C true CN1308021C (en) 2007-04-04

Family

ID=34146490

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021364745A Expired - Fee Related CN1308021C (en) 2002-08-13 2002-08-13 Antivirus oral liquid

Country Status (1)

Country Link
CN (1) CN1308021C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940856B (en) * 2012-12-12 2014-03-19 杭州老桐君制药有限公司 Method for preparing anti-viral oral liquid and product thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1137400A (en) * 1996-01-15 1996-12-11 贺力坤 Method for preparation of drug for curing acute epidemic febrile disease
CN1244421A (en) * 1999-05-27 2000-02-16 刘成业 Preparation of antiviral Guzaoke

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1137400A (en) * 1996-01-15 1996-12-11 贺力坤 Method for preparation of drug for curing acute epidemic febrile disease
CN1244421A (en) * 1999-05-27 2000-02-16 刘成业 Preparation of antiviral Guzaoke

Also Published As

Publication number Publication date
CN1475244A (en) 2004-02-18

Similar Documents

Publication Publication Date Title
CN102784282A (en) Medicine for clearing heat, removing toxicity and reducing fever
CN101322776A (en) Chinese medicinal composition for treating exogenous fever and preparation thereof
CN103381266A (en) Traditional Chinese medicine for treating nervous vomiting
CN103479947B (en) The preparation method of control constipation medicine
CN1308021C (en) Antivirus oral liquid
CN104623379B (en) A kind of pharmaceutical composition for the treatment of Hand-Food-Mouth Disease
CN102793876A (en) Pharmaceutical composition for treating fever caused by unknown reason as well as preparation method and application of pharmaceutical composition
CN102600343A (en) Chinese medicinal preparation for treating oral diseases and/or toothache
CN101336990B (en) Medicine for treating cholecystitis
CN103006950A (en) Traditional Chinese medicine for treating pharyngolaryngitis and preparation process thereof
CN104225387A (en) Traditional Chinese medicine composition for treating damp-heat blocked type diabetes feet
CN104474492A (en) Traditional Chinese medicine composition for treating externally contracted wind evil and preparation method
CN103479986B (en) The anti-medicine treated constipation
CN103479948B (en) The anti-medicine treated constipation
CN102552789A (en) Chinese medicine for treating damp-warm flu and preparation method and application thereof
CN100409884C (en) Chinese traditional medicine for treating cold
CN100490873C (en) Medicinal composition for treating high fever and preparation method thereof
CN100345567C (en) Medicine for treating functional headache
CN104324080B (en) The injection for the treatment of upper respiratory tract infection and preparation method
CN104435232B (en) A kind of Chinese medicine composition for treating toothache
CN103520624B (en) The anti-medicine treated constipation
CN102743526B (en) Preparation method of Chinese medicine irrigation solution for treating edema type chronic cervicitis
CN102688382B (en) Gamene oral liquid for treating acute gastroenteritis and preparation method thereof
CN102475874A (en) Tablet for soothing liver and tonifying spleen
CN111265612A (en) Traditional Chinese medicine mixture for preventing and treating influenza epidemic

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee